logo
Wrong email address or username
Wrong email address or username
Incorrect verification code
back to top
Search tags: American-Novel
Load new posts () and activity
Like Reblog Comment
text 2022-01-14 10:35
North American Nuclear Medicine Market : Global Analysis, Opportunities And Forecast - 2024

[159 Pages Report] The North American nuclear medicine market is expected to reach USD 2.7 billion by 2024 from an estimated USD 2.2 billion in 2019, growing at a CAGR of 4.1% during the forecast period.

The study involved four major activities in estimating the current size for the North American nuclear medicine market. Exhaustive secondary research was done to collect information on the market and its different subsegments. The next step was to validate these findings, assumptions, and sizing with industry experts across the value chain through primary research. Both top-down and bottom-up approaches were employed to estimate the complete market size.

Market Dynamics

  • Increasing Incidence and Prevalence of Target Conditions
  • Alpha Radioimmunotherapy-Based Targeted Cancer Treatment
  • Initiatives to Lessen the Demand-Supply Gap of Mo-99

The increasing adoption of automated inspection systems in the pharmaceutical and biotechnology industries, growth in the number of product recalls, an increasing number of inspection checkpoints throughout the production line, and technological advancements in inspection systems support the growth of the market.

Download PDF Brochure@   https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=1108 

Based on type, the market is categorized into diagnostic and therapeutic nuclear medicine. The therapeutic nuclear medicine segment is further segmented into alpha emitters, beta emitters, and brachytherapy isotopes.

The geographical regions mapped in the report are:

1. North America

2. US

3. Canada

Geographically, the North American market comprises of US and Canada. In 2018, the US accounted for the largest share of the nuclear medicine market. The large share can be attributed to the development of novel technologies for radioisotope production, government funding, and company initiatives in the country.

Based on application, the North American nuclear medicine market is segmented into SPECT, PET, and therapeutic applications. The SPECT applications segment is further segmented into cardiology, bone scans, thyroid applications, pulmonary scans, and other SPECT applications. The thyroid applications segment is projected to register the highest growth rate in the forecast period. The high growth of this segment can be attributed to the increasing incidence and prevalence of thyroid disorders.

Request for sample pages @  https://www.marketsandmarkets.com/requestsampleNew.asp?id=1108 

Like Reblog Comment
text 2021-11-26 09:07
North American Nuclear Medicine Market : Global Analysis, Opportunities And Forecast - 2024

[159 Pages Report] The North American nuclear medicine market is expected to reach USD 2.7 billion by 2024 from an estimated USD 2.2 billion in 2019, growing at a CAGR of 4.1% during the forecast period.

The study involved four major activities in estimating the current size for the North American nuclear medicine market. Exhaustive secondary research was done to collect information on the market and its different subsegments. The next step was to validate these findings, assumptions, and sizing with industry experts across the value chain through primary research. Both top-down and bottom-up approaches were employed to estimate the complete market size.

Market Dynamics

  • Increasing Incidence and Prevalence of Target Conditions
  • Alpha Radioimmunotherapy-Based Targeted Cancer Treatment
  • Initiatives to Lessen the Demand-Supply Gap of Mo-99

The increasing adoption of automated inspection systems in the pharmaceutical and biotechnology industries, growth in the number of product recalls, an increasing number of inspection checkpoints throughout the production line, and technological advancements in inspection systems support the growth of the market.

Download PDF Brochure@   https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=1108 

Based on type, the market is categorized into diagnostic and therapeutic nuclear medicine. The therapeutic nuclear medicine segment is further segmented into alpha emitters, beta emitters, and brachytherapy isotopes.

The geographical regions mapped in the report are:

1. North America

2. US

3. Canada

Geographically, the North American market comprises of US and Canada. In 2018, the US accounted for the largest share of the nuclear medicine market. The large share can be attributed to the development of novel technologies for radioisotope production, government funding, and company initiatives in the country.

Based on application, the North American nuclear medicine market is segmented into SPECT, PET, and therapeutic applications. The SPECT applications segment is further segmented into cardiology, bone scans, thyroid applications, pulmonary scans, and other SPECT applications. The thyroid applications segment is projected to register the highest growth rate in the forecast period. The high growth of this segment can be attributed to the increasing incidence and prevalence of thyroid disorders.

Request for sample pages @  https://www.marketsandmarkets.com/requestsampleNew.asp?id=1108 

Source: www.marketsandmarkets.com/Market-Reports/north-american-nuclear-medicine-radiopharmaceuticals-market-1108.html
Like Reblog Comment
text 2021-10-12 12:21
Why will North American Defibrillators Market Exhibit Rapid Progress in U.S in Coming Years?

Driven by the soaring geriatric population, increasing prevalence of cardiac disorders, ballooning requirement of automated external defibrillators (AEDs), and rapid developments and innovations in defibrillation technology, the North American defibrillators market is predicted to grow, in valuation, from $6.1 billion to $8.1 billion from 2017 to 2023. Furthermore, as per the predictions of P&S Intelligence, a market research firm based in India, the market will exhibit a CAGR of 4.9% from 2018 to 2023.

 

Browse report overview and detailed TOC at North American Defibrillators Market Demand Forecast 

 

The surging geriatric population in many North American countries is one of the major factors responsible for the growth of the North American defibrillators market. In North America, the population of geriatric people is growing at the fastest rate in the U.S. As per the report published by the Population Reference Bureau in 2018, the total number of people in the age bracket (65 years and above) in the U.S. is predicted to rise from 46 million to more than 98 million during 2014—2060.

 

Public access settings, hospitals, clinics, and cardiac centers, home care settings, and pre-hospital care settings are the main categories present under the end user segmentation of the market. Out of these categories, the hospitals, clinics, and cardiac centers category generated the highest revenue in the market over the last few years. However, the fastest market growth will be exhibited by the public access settings category in the future years, owing to the ballooning utilization of AEDs in this category.

 

The North American defibrillators market is also expected to exhibit rapid growth in Canada over the next few years. This is primarily attributed to the rising government incentives and measures being taken in the country, such as investments and other initiatives, for increasing awareness and providing defibrillation training to the people, increasing incidence of cases of sudden cardiac arrests, and the existence of several local defibrillators supplying companies in the country.

Like Reblog Comment
text 2021-08-30 10:51
North American Nuclear Medicine Market : Global Analysis, Opportunities And Forecast

[159 Pages Report] The North American nuclear medicine market is expected to reach USD 2.7 billion by 2024 from an estimated USD 2.2 billion in 2019, growing at a CAGR of 4.1% during the forecast period.

The study involved four major activities in estimating the current size for the North American nuclear medicine market. Exhaustive secondary research was done to collect information on the market and its different subsegments. The next step was to validate these findings, assumptions, and sizing with industry experts across the value chain through primary research. Both top-down and bottom-up approaches were employed to estimate the complete market size.

Market Dynamics

  • Increasing Incidence and Prevalence of Target Conditions
  • Alpha Radioimmunotherapy-Based Targeted Cancer Treatment
  • Initiatives to Lessen the Demand-Supply Gap of Mo-99

The increasing adoption of automated inspection systems in the pharmaceutical and biotechnology industries, growth in the number of product recalls, an increasing number of inspection checkpoints throughout the production line, and technological advancements in inspection systems support the growth of the market.

Download PDF Brochure@  https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=1108

Based on type, the market is categorized into diagnostic and therapeutic nuclear medicine. The therapeutic nuclear medicine segment is further segmented into alpha emitters, beta emitters, and brachytherapy isotopes.

The geographical regions mapped in the report are:

1. North America

2. US

3. Canada

Geographically, the North American market comprises of US and Canada. In 2018, the US accounted for the largest share of the nuclear medicine market. The large share can be attributed to the development of novel technologies for radioisotope production, government funding, and company initiatives in the country.

Based on application, the North American nuclear medicine market is segmented into SPECT, PET, and therapeutic applications. The SPECT applications segment is further segmented into cardiology, bone scans, thyroid applications, pulmonary scans, and other SPECT applications. The thyroid applications segment is projected to register the highest growth rate in the forecast period. The high growth of this segment can be attributed to the increasing incidence and prevalence of thyroid disorders.

Request for sample pages @  https://www.marketsandmarkets.com/requestsampleNew.asp?id=1108

Some key players mentioned in the research report are:

Cardinal Health (US), GE Healthcare (US), Curium (France), Lantheus Medical Imaging (US), Bayer AG (Germany), Bracco Imaging (OTCPK:ITALY), Eczacýbaþý-Monrol Nuclear Products (Turkey), Nordion (Canada), Advanced Accelerator Applications (France), and NTP Radioisotopes (South Africa).

Source: www.marketsandmarkets.com/Market-Reports/north-american-nuclear-medicine-radiopharmaceuticals-market-1108.html
More posts
Your Dashboard view:
Need help?